With a sturdy clinical-phase pipeline, Agenus harnesses a combination of proprietary antibody platforms, such as Retrocyte Display screen™ and SECANT®, and ground breaking cell therapy strategies, positioning by itself to be a essential contributor in the biotechnology and immunotherapy arena.These built-in systems permit for the event of equall